Cargando…
Baseline serum TSH levels predict the absence of thyroid dysfunction in cancer patients treated with immunotherapy
PURPOSE: Immunotherapy against immune checkpoints has significantly improved survival both in metastatic and adjuvant setting in several types of cancers. Thyroid dysfunction is the most common endocrine adverse event reported. Patients who are at risk of developing thyroid dysfunction remain to be...
Autores principales: | Brilli, L., Danielli, R., Campanile, M., Secchi, C., Ciuoli, C., Calabrò, L., Pilli, T., Cartocci, A., Pacini, F., Di Giacomo, A. M., Castagna, M. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285335/ https://www.ncbi.nlm.nih.gov/pubmed/33367977 http://dx.doi.org/10.1007/s40618-020-01480-6 |
Ejemplares similares
-
CONUT Score: A New Tool for Predicting Prognosis in Patients with Advanced Thyroid Cancer Treated with TKI
por: Dalmiglio, Cristina, et al.
Publicado: (2022) -
Permanent diabetes insipidus in a patient with mesothelioma treated with immunotherapy
por: Brilli, Lucia, et al.
Publicado: (2020) -
The Combination of Sonographic Features and the Seven-Gene Panel May be Useful in the Management of Thyroid Nodules With Indeterminate Cytology
por: Capezzone, Marco, et al.
Publicado: (2021) -
Effects of Acute Recombinant Human TSH on Serum Ghrelin Levels
por: Ciuoli, Cristina, et al.
Publicado: (2011) -
Improvement of Overall Survival Using TKIs as Salvage Therapy in Advanced Thyroid Carcinoma: Real-Life Data on a Single Center Experience
por: Brilli, Lucia, et al.
Publicado: (2021)